E Point Perfect
Law \ Legal

New data shows Alzheimer’s drug can slow cognitive decline


A phase III clinical trial that published results earlier this week in the New England Journal of Medicine shows promising data that Alzheimer’s drug, Lecanemab by Eisai and Biogen Inc, can slow cognitive decline. “Lecanemab reduced markers of amyloid in…


Source link

Related posts


‘Problematic’ order for contribution to undefined future expenses set aside by BC Court of Appeal

Joint Committee report on risks and vulnerabilities in the EU financial system

#WhyIAmASolo – I Am In Control Of The Cookie Jar.

California’s New Children’s Privacy Law is Set to Come into Effect in 2024

In a Big Win for California Employers, SCOTUS Limits the Reach of the Golden State’s Private Attorneys General Act of 2004